ARTICLE | Distillery Therapeutics
Therapeutics: Epstein-Barr virus envelope glycoprotein gp350 (BLLF1); ferritin
September 3, 2015 7:00 AM UTC
Mouse studies suggest vaccine nanoparticles engineered to display the BLLF1 ectodomain could help prevent EBV infection. The vaccine nanoparticles consisted of the BLLF1 ectodomain fused to the N-term...